THE COMPARATIVE EFFECTIVENESS OF CYCLING TUMOURNECROSIS FACTOR INHIBITOR (TNFI) VERSUS SWAPPING TO A NONTNFI ON PATIENT-REPORTED FUNCTIONAL ABILITY OF PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0

作者：

Lopez-Oliva, M. A. ^{[1
]}

Matusevich, A. ^{[1
]}

Cantor, S. B. ^{[2
]}

Pratt, G. ^{[3
]}

Suarez-Almazor, M. E. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Gen Internal Med, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Hlth Serv Res, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Res Med Lib, Houston, TX 77030 USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷

关键词：

D O I：

10.1136/annrheumdis-2018-eular.6989

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0298

引用

页码：196 / 196

页数：1

共 50 条

[21] FACTORS INFLUENCING SELECTION OF BIOLOGIC THERAPY AND COMPARATIVE EFFECTIVENESS IN PATIENT REPORTED OUTCOMES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS [J].

Curtis, J. R. ;

Navarro-Millan, I. ;

Chen, L. ;

Harrold, L. R. ;

Liu, L. .

ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 :554-554

[22] Cycling Versus Swapping in Patients with Rheumatoid Arthritis with an Inadequate Response to at Least One Tumor Necrosis Factor Alpha Inhibitor: A Systematic Review and Meta-Analysis of Observational Studies [J].

Lopez-Olivo, Maria A. ;

Matusevich, Aliza ;

Suarez-Almazor, Maria .

ARTHRITIS & RHEUMATOLOGY, 2017, 69

[23] CYCLING VERSUS SWAPPING IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO AT LEAST ONE TUMOR NECROSIS FACTOR ALPHA INHIBITOR: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES [J].

Lopez-Olivo, M. A. ;

Matusevich, A. ;

Suarez-Almazor, M. E. .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 :851-851

[24] COMPARATIVE EFFECTIVENESS OF RITUXIMAB VERSUS ANTI-TUMOR NECROSIS FACTOR SWITCHING FOR RHEUMATOID ARTHRITIS PATIENTS [J].

Harrold, L. ;

Reed, G. ;

Magner, R. ;

Shewade, A. ;

John, A. ;

Reiss, W. ;

Greenberg, J. ;

Kremer, J. .

ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 :460-460

[25] Comparative Effectiveness of Tocilizumab (TCZ) Monotherapy with Tumor Necrosis Factor Inhibitors (TNFi) in Combination with Varying Doses of Methotrexate (MTX) in Patients with Rheumatoid Arthritis [J].

Harrold, Leslie R. ;

Reed, George W. ;

Best, Jennie ;

Zlotnick, Steve ;

Persuitte, Gioia ;

Kremer, Joel .

ARTHRITIS & RHEUMATOLOGY, 2017, 69

[26] COMPARATIVE EFFECTIVENESS OF TOCILIZUMAB (TCZ) MONOTHERAPY WITH TUMOR NECROSIS FACTOR INHIBITORS (TNFI) IN COMBINATION WITH VARYING DOSES OF METHOTREXATE (MTX) IN PATIENTS WITH RHEUMATOID ARTHRITIS [J].

Harrold, L. R. ;

Reed, G. W. ;

Best, J. ;

Zlotnick, S. ;

Persuitte, G. ;

Kremer, J. M. .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 :1191-1192

[27] Comparative Effectiveness Of Rituximab Vs. Subsequent Anti-Tumor Necrosis Factor In Patients With Rheumatoid Arthritis With Prior Exposure To TNFi. [J].

Harrold, Leslie R. ;

Reed, George W. ;

Magner, Robert P. ;

Shewade, Ashwini ;

John, Ani ;

Greenberg, Jeffrey D. ;

Kremer, Joel M. .

ARTHRITIS AND RHEUMATISM, 2013, 65 :S610-S610

[28] Systematic Review of Economic Evaluations of Cycling Versus Swapping Medications in Patients With Rheumatoid Arthritis After Failure to Respond to Tumor Necrosis Factor Inhibitors [J].

Karpes Matusevich, Aliza R. ;

Suarez-Almazor, Maria E. ;

Cantor, Scott B. ;

Lal, Lincy S. ;

Swint, J. Michael ;

Lopez-Olivo, Maria A. .

ARTHRITIS CARE & RESEARCH, 2020, 72 (03) :343-352

[29] COMPARATIVE DISEASE BURDEN IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: DATA FROM COVAD PATIENT-REPORTED E-SURVEY [J].

Venerito, V. ;

Fornaro, M. ;

Iannone, F. ;

Cavagna, L. ;

Kuwana, M. ;

Agarwal, V. ;

Ravichandran, N. ;

Day, J. ;

Joshi, M. ;

Saha, S. ;

Shaharir, S. S. ;

Katchamart, W. ;

Goo, P. A. ;

Traboco, L. ;

Chen, Y. M. ;

Sen, P. ;

Lilleker, J. B. ;

Nune, A. ;

Pauling, J. ;

Wincup, C. ;

Tan, A. L. ;

Ziade, N. ;

Milchert, M. ;

Gracia-Ramos, A. E. ;

Caballero, C. Vinicio ;

Study, C. ;

Agarwal, V. ;

Aggarwal, R. ;

Gupta, L. .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :746-747

[30] Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis [J].

Vibeke Strand ;

Laure Gossec ;

Clare W. J. Proudfoot ;

Chieh-I Chen ;

Matthew Reaney ;

Sophie Guillonneau ;

Toshio Kimura ;

Janet van Adelsberg ;

Yong Lin ;

Erin K. Mangan ;

Hubert van Hoogstraten ;

Gerd R. Burmester .

Arthritis Research & Therapy, 20

← 1 2 3 4 5 →